Abstract:BACKGROUND Transhepatic arterial chemoembolization (TACE), as a local treatment, has been widely used in the treatment of unresectable liver cancer. The introduction of drug carrier microspheres has brought new hope for the therapeutic effect of TACE. Microspheres can realize the slow release and directional delivery of drugs, reduce systemic toxicity and improve local curative effect. AIM To compare the effectiveness of traditional transcatheter arterial chemoembolization against microsphere-assisted transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma that is incurable. METHODS We searched the PubMed, Embase, Cochrane Library, and CNKI databases for clinical trials of drug-luting beads TACE (DEB-TACE) vs conventional TACE (cTACE) for the treatment of unresectable liver cancer. We screened references based on inclusion and exclusion criteria and then selected valid data for meta-analysis using RevMan 53 software. The complete response (CR) rate, partial response (PR) rate, postoperative stable disease (SD) rate, and 6-month and 12-month survival rates were compared. RESULTS A total of 12 articles were included, including 1177 patients, 519 of whom received DEB-TACE and 658 of whom received cTACE. The CR rate in the DEB-TACE group was much greater than that in the cTACE group [relative risk (RR) = 1.42, 95%CI: 1.18–1.72, P = 0.0002]. The 12-month survival rate significantly increased (RR = 1.09; 95%CI: 1.01- 1.17, P = 0.03); the PR rate (RR = 1.13; 95%CI: 0.97-1.30, P = 0.12); the SD rate (RR = 0.82; 95%CI: 0.64-1.05, P = 0.12); and the 6-month survival rate (RR = 1.05; 95%CI: 1.00-1.10, P = 0.07). There was no significant difference (P < 0.05). CONCLUSION Compared with those of iodized oil TACE, the drug-loaded microspheres tended to have therapeutic advantages.

Technical Details and Progress of Transcatheter Hepatic Arterial Chemoembolization

Superstable Homogeneous Iodinated Formulation Technology: Revolutionizing Transcatheter Arterial Chemoembolization

Recent Advances on Bile Duct Injury after Transcatheter Arterial Chemoembolization for Hepatic Malignancy

Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma

Transarterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma:Recent Progress in Research

Advances in Endovascular Therapy to Treat Primary Hepatocellular Carcinoma

The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicine

Transarterial chemoembolization refractory: current research progress

TACE by using microspheres and lipiodol for the treatment of hepatocellular carcinoma: analysis of short-term efficacy

Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma

Advanced Imaging Techniques in the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma

Current Trends in the Treatment of Hepatocellular Carcinoma with Transarterial Embolization: Variability in Technical Aspects

He Relationship Between the Tumor Tissue Reaction and Transcatheter Arterial Chemoembolization Methods for Hepatocellular Carcinoma

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

[Transcatheter Hepatic Arterial Chemoembolization on Recurrent Hepatocellular Carcinoma after Resection].

Transarterial chemoembolization refractoriness in hepatocellular carcinoma: Chinese College of Interventionalists definition and consensus statement

Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma:its research progress

Transarterial Chemoembolization in Hepatocellular Carcinoma with Vascular Invasion or Extrahepatic Metastasis: A Systematic Review

Efficacy and safety of transhepatic arterial chemoembolization with drug-loaded microspheres in unresectable primary liver cancer

Surgical and Locoregional Therapy of HCC: TACE

Role of Post-Operative Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma with Different Pathological Characteristics